MAGNA™ can be used to study the interactions of small molecule therapeutics with their targets in real-time at the single-molecule level, revealing the dynamics of the binding events in high-definition. MAGNA™ will provide powerful new insights into both target validation and hit-to-lead areas of drug development.
Nothing in biology acts alone: everything acts in conjunction, opposition, and synergy with other elements. MAGNA™ visualizes these complex interactions enabling researchers to better understand the underlying causes, and identify new ways of treating disease.